Riskpilot← Back to searchSign inGet full accessBiozymes ApS
APSActiveCVR 30587979Kroghsvej 58Wholesale of other food · NACE 4638Est. 20071 employees
Revenue 2025
DKK -28K
-163% vs 2024
EBITDA margin
117.6%
-226% vs 2024
Equity ratio
-716.8%
Financial strength
Net profit 2025
DKK -112K
-145% vs 2024
| Revenue | DKK -28K | -163% |
| EBITDA | DKK -33K | -226% |
| Net profit | DKK -112K | -145% |
| Total assets | DKK 146K | +27% |
| Equity | DKK -1M | -12% |
| Employees | 1 | — |
Legal name
Biozymes ApS
CVR number
30587979
Legal form
Anpartsselskab
NACE code
4638 · Wholesale of other food
Founded
15. maj 2007
Share capital
DKK 125.000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør eller den samlede direktion.
Company purpose
Virksomhedens formål er Teknologiudvikling og salg af naturlige konserveringsmidler også kaldet Bacteriocines og hermed beslægtet virksomhed.
Address
Kroghsvej 58
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | -16 | -170 | -591 | 44 | -28 |
| Staff expenses | -0 | -0 | -18 | -18 | -5 |
| EBITDA | -16 | -170 | -608 | 26 | -33 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 |
| EBIT | -16 | -170 | -608 | 26 | -33 |
| Net financials | 2 | -16 | -33 | -72 | -79 |
| Profit before tax | -15 | -186 | -642 | -46 | -112 |
| Tax | -1 | -0 | -0 | -0 | -0 |
| Net profit | -14 | -186 | -642 | -46 | -112 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 126 | 96 | 291 | 115 | 146 |
| Equity | 98 | -88 | -729 | -937 | -1.049 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 27 | 184 | 1.020 | 1.052 | 1.196 |
| Total debt | 27 | 184 | 1.020 | 1.052 | 1.196 |
EBITDA margin
-3283000.0%
This company
15.8%
Market median
-20778581% vs market
20212025
Equity ratio
-716.8%
This company
38.2%
Market median
-1976% vs market
20212025
Return on equity
-11177900.0%
This company
18.4%
Market median
-60749557% vs market
20212025
Net profit margin
-11177900.0%
This company
8.1%
Market median
-137998865% vs market
20212025
Asset turnover
-0.19×
This company
1.12×
Market median
-117% vs market
20212025
Debt / equity
1.14×
This company
0.62×
Market median
-84% vs market
20212025
- Annual report 2025Filed via CVR / Virk · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via CVR / Virk · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via CVR / Virk · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via CVR / Virk · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via CVR / Virk · Period 2020-07-01 – 2021-06-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
HO Management | Management | 2025 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100% | 100% | 2022 | |
| Individual | 50–66.65% | 50–66.65% | 2017 | |
| Individual | 50–66.65% | 50–66.65% | 2017 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Biozymes ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Heidi Obitsø Kristensen | Management | 0 companies |